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Edited by Richard MaraisAbstract The C-Raf kinase is regulated by numerous phosphor-
ylation steps. To quantify the most prominent phosphorylation
sites of C-Raf, we performed mass spectrometry analysis of
wild-type C-Raf and the constitutively active C-Raf mutant C-
Raf-Y340D/Y341D. We conﬁrmed phosphorylation of most of
the sites reported in the literature with the exception that we
did not detect phosphorylation of threonine 268/269 (autophos-
phorylation sites) and threonine 491/serine 494 (kinase activation
loop). Importantly, we detected novel phosphorylation sites at
the positions of serine 296 and 301. The degree of phosphoryla-
tion in these positions depends on the level of activation of C-
Raf. Furthermore, we show here, using point mutant forms of
C-Raf kinases with serine to alanine and serine to aspartic acid
substitution, that serines 296 and 301 contribute to negative reg-
ulation of C-Raf.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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spectrometry1. Introduction
Raf proteins belong to the family of serine/threonine-speciﬁc
protein kinases that control cell proliferation, transformation,
diﬀerentiation and apoptosis [1,2]. In mammals, three closely
related Raf isoforms exist, designated as A-, B- and C-Raf.
Raf kinases serve as signaling modules for the classical mito-
genic signaling cascade, functioning to connect receptor tyro-
sine kinases and Ras in the plasma membrane via MEK and
ERK with nuclear transcription factors. All Raf isoforms share
three conserved regions (CR1, CR2 and CR3) and possess two
functional domains, the amino-terminal regulatory domain and
the carboxy-terminal kinase domain. In C-Raf, the regulatoryAbbreviations: MS, mass spectrometry; RBD, Ras-binding domain;
CRD, cysteine rich domain; NP-40, Nonidet P-40; LC, liquid chro-
matography; LC/MS-MS/MS, data-dependent tandem LC/MS
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doi:10.1016/j.febslet.2004.11.105domain includes residues 51–194 (CR1) and residues 254–269
(CR2). CR3 represents the kinase domain extending from res-
idues 347 to 613 (see also Fig. 1). Within CR1, the Ras-binding
domain (RBD) is located followed by the cystein-rich region
(CRD). Binding sites for 14-3-3 proteins are located in CR2
and CR3 and are similar for all three Raf isoforms.
Despite intensive investigations, the mechanism of Raf regu-
lation is still not completely elucidated. Our current model sug-
gests that speciﬁc Raf association with plasma membrane lipids
(and lipid microdomains) represents the prerequisite step in the
Raf activation process [3]. Upon stimulation of cell surface
receptors, coupling of Ras to RBD (and possibly CRD) initi-
ates the complex mechanism of Raf activation including diﬀer-
ential association with 14-3-3 proteins, dimerization and
phosphorylation-dephosphorylation events. The three most
prominent sites of C-Raf phosphorylation have been identiﬁed
as serines 43, 259 and 621 [4]. Phosphorylation of serines in
positions 259 and 621 represents the most prominent binding
sites for 14-3-3 proteins. Recently, it has been reported that
phosphorylation of serines 43, 233 and 259 by protein kinase
A results in negative regulation of C-Raf function [5]. In con-
trast, phosphorylation of C-Raf serine 338 correlates with
Ras mediated stimulation and is required for Raf activation
[6]. Much attention has been devoted to the role of phosphor-
ylation of tyrosine 340/341 in C-Raf activation, since conver-
sion of these residues to aspartic acid results in a
constitutively active form of C-Raf [6,7]. The role (and origin)
of tyrosine phosphorylation in positions 340/341 is still unclear.
Originally, phosphorylation of tyrosine 340/341 has been as-
cribed to phosphorylation by receptor tyrosine kinases and
the Src family of kinases. In some cell types, tyrosine 340/341
phosphorylations have been shown to be coincident with Raf
activation [8,9]. On the other hand, it was not always possible
to demonstrate tyrosine phosphorylation in activated Raf,
leading to the conclusion that Raf tyrosine phosphorylation
may be receptor- and/or cell-type dependent. Thus, direct tyro-
sine phosphorylation of Raf by tyrosine receptor kinases re-
mains a possibility [8] and is currently under investigation in
our laboratory. Threonine residues 268/269 have been reported
to serve as autophosphorylation sites and targets for KSR
[4,10]. Furthermore, serines 479 and 499 were described as
protein kinase C phosphorylation sites [11,12]. Recently,
Chong et al. demonstrated that phosphorylations of threonine
491 and serine 494 positioned in the activation loop of C-Raf
are necessary, but not suﬃcient, for C-Raf activation [13].blished by Elsevier B.V. All rights reserved.
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Fig. 1. Schematic representation of C-Raf kinase. The most prominent phosphorylation sites including serines 296 and 301 are indicated.
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341 and further augment C-Raf activation. Negative regulation
of C-Raf by phosphorylation has also been reported: phos-
phorylation of serine 259 was proposed to inactivate C-Raf,
probably by promoting the formation of a Raf autoinhibitory
complex via association with 14-3-3 proteins.
In order to address how phosphorylation events inﬂuence
and regulate the activation cycle of C-Raf, we performed a de-
tailed quantitative analysis of C-Raf phosphorylation using
mass spectrometry (MS). For that purpose, we compared the
phosphorylation status of C-Raf wild-type with the constitu-
tively active mutant of C-Raf (C-Raf-Y340D/Y341D). We
found that the degree of phosphorylation of 14-3-3 binding
sites at serines 259 and 621 was similar for both C-Raf samples
analyzed. However, the active C-Raf mutant was not phos-
phorylated in positions serine 338, threonine 491 and serine
494, indicating that phosphorylation of these residues is not
necessarily required for active state of C-Raf. Furthermore,
we detected novel phosphorylation sites at the positions of ser-
ine 296 and 301. To investigate the functional role of these
phosphorylation sites, we cloned and puriﬁed C-Raf mutants
possessing either alanine or aspartic acid residues in these posi-
tions. Exchange of serine by alanine resulted in enhancement
of kinase activity, whereas incorporation of aspartic acid did
not change the level of activity. We conclude that serines 296
and 301 participate in the regulation of Raf activity.2. Materials and methods
2.1. Materials
Benzamidine, leupeptin, aprotinin, PMSF and Nonidet P-40 were
obtained from Sigma. Glutathione–Sepharose were purchased from
Amersham Biosciences and Ni–NTA–Agarose from Qiagen. EGF
was from CellSystems (PeproTech EC Ltd). Monoclonal anti-phos-
pho-ERK antibodies were from New England Biolabs. Rabbit poly-
clonal anti-C-Raf was from BioSource and anti-GFP (FL) from
Santa Cruz (sc-8334). Horseradish peroxidase-conjugated polyclonal
anti-rabbit and anti-mouse IgG were obtained from Amersham Bio-
sciences.
2.2. Cloning of His6- and GFP-tagged Raf genes
Human C-Raf wt and C-Raf mutants such as point mutants C-Raf-
S296A/296D and C-Raf-301A/301D as well as the double mutants
have been modiﬁed to introduce the recognition sequence for NheI
immediately upstream of ATG codon. In addition, adenine of ATGwas converted into cytidine, which changes this codon from methio-
nine into leucine. The modiﬁed gene was cleaved with NheI and sticky
ends were ﬁlled-in with Klenow enzyme + dNTPs. After heat inactiva-
tion of the polymerase, the C-Raf-containing fragment was released by
further digestion with XbaI and ligated into BamHI (ﬁlled-in with
Klenow enzyme + dNTPs as described above) – XbaI-cleaved pFast-
Bac-Hta (Invitrogen). C-Raf protein expressed by this system was N-
terminally extended by 28 amino acids, including a 6·histidine tag
for aﬃnity puriﬁcation on Ni–NTA matrix. For attachment of GFP-
group to C-Raf kinases, BamHI–XhoI fragments of c-Rafwt coding
sequence and its mutants were ligated into BglII–SalI cleaved
pEGFP-C1 (Clontech). These extensions did not inﬂuence biological
properties of Raf kinases in vivo or in vitro.2.3. Infection of Sf9 insect cells, puriﬁcation of Raf kinases, SDS–PAGE
and Western blot analysis
For the production of recombinant Raf kinases, Sf9 cells were in-
fected with the desired baculoviruses at a multiplicity of infection of 5
and incubated for 48 h at 30 C. The cells were then washed with
PBS-buﬀer and pelleted at 1100 rpm. The Sf9 cell pellets (2 · 108
cells) were lysed in 10 ml Nonidet P-40 (NP-40) lysis buﬀer contain-
ing 25 mM Tris–HCl, pH 7.6, 150 mM NaCl, 10 mM Na-pyrophos-
phate, 25 mM b-glycerophosphate, 25 mM NaF, 10% glycerol, 0.75%
NP-40 and a cocktail of standard proteinase inhibitors for 45 min
with gentle rotation at 4 C. The lysate was centrifuged at
27000 · g for 30 min at 4 C. The supernatants containing GST-
tagged Raf kinases were incubated with 0.5 ml glutathione–Sepharose
beads for 2 h at 4 C with rotation. After incubation, the beads were
washed three times with NP-40 buﬀer. Raf kinases bound to the
beads were eluted with 0.5 ml of 25 mM Tris–HCl, pH 7.6, 150
mM NaCl, 25 mM b-glycerophosphate, 25 mM NaF, 10% glycerol,
0.1% NP-40 and 20 mM glutathione. The puriﬁcation procedure
for his-tagged Raf kinases was similar as described above with the
exception that the Sf9 cell lysates were incubated with 0.5 ml of
Ni–NTA–Agarose. The bound proteins were then eluted with imidaz-
ole using a step gradient. To reduce the interference to MS analysis
due to the non-ionic detergent NP-40, most GST-C-Raf preparations
were puriﬁed in the presence of octyl-glucoside. The purity of Raf ki-
nases was documented by SDS–PAGE (10% gels) and staining with
Coomassie Blue (Fig. 2). For Western blot analysis, the gels were
transferred to nitrocellulose membranes (Schleicher & Schuell) and
probed with antibodies speciﬁc for C-Raf and phospho-ERK. After
washing, the membranes were incubated with speciﬁc secondary
horseradish peroxidase conjugated antibodies and detected by en-
hanced chemiluminescence (ECL, Amersham).2.4. Cell transfection and kinase activity measurements
COS-7 cells were transfected by Ca2+ phosphate precipitation using
equal amounts of plasmids coding to diﬀerent C-Raf constructs as
indicated in Fig. 4. Following starvation of cells for 48 h and EGF
(100 ng/ml) stimulation, the cells were lysed with NP-40 lysis buﬀer.
Fig. 2. Puriﬁcation of C-Raf kinases. Sf9 insect cells were infected with
baculoviruses encoding either GST- (A) or His-tagged (B) Raf kinases.
The recombinant Raf was puriﬁed either by glutathione–Sepharose or
nickel chelate aﬃnity chromatography, subjected to SDS–PAGE (10%
gels) and stained by Coomassie Blue. In (B), only C-Raf wt and C-Raf
serine 296 mutants are shown. A similar degree of purity was achieved
for serine 301 mutated proteins (data not shown). 14-3-3 proteins and
HSP90 were co-puriﬁed with both GST-C-Raf and His-C-Raf as
indicated.
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were used directly for measurements of C-Raf kinase activity. Kinase
assays with Raf samples were performed using recombinant MEK
and ERK-2 as substrates in 25 mM HEPES, pH 7.6, 150 mM NaCl,
25 mM b-glycerophosphate, 10 mM MgCl2, 1 mM DTT and 0.2 mM
sodium vanadate buﬀer (50 ll ﬁnal volume). Following addition of
Raf-containing samples, the reaction mixtures were incubated for
30 min at 26 C. The incubation was terminated by addition of Lae-
mmli sample buﬀer, the proteins were separated by 10% SDS–PAGE
and transferred to nitrocellulose membranes using standard methods.
The extent of ERK phosphorylation was determined by anti phos-
pho-ERK antibodies.
2.5. Mass spectrometry measurements
The baculovirus expressed and puriﬁed GST-tagged C-Raf kinases
(about 0.5 nmol of each) were denatured, reduced and alkylated
using guanidine HCl, DTT and iodoacetamide. The samples were
buﬀer exchanged and concentrated with Amicon Y30 in the presence
of phosphatase inhibitors (ﬁnal buﬀer was: 100 mM ammonium
bicarbonate, 2 M urea and 0.5% w/v octyl-glucoside). Trypsin diges-
tion was performed overnight at a trypsin to protein ratio of 1:50 (w/
w) and the resulting peptides were analyzed by LC/MS. A Vydac C-
18 column (1 · 150 mm) was used for separation with a gradient of
2% B–40% B–90% B at 0–40–60 min, where A was 0.1% formic acid
in water (v/v) and B was 0.1% formic acid in acetonitrile. For selec-
tive detection of phosphopeptides, a Sciex API III triple quadrupole
mass spectrometer with electrospray ionization source was used in the
Parent Ion Scanning mode of m/z 79 (negative mode operation).
Ammonium hydroxide was infused into the LC ﬂow post column
to achieve a 0.5% (v/v) concentration to aid the MS detection at neg-
ative mode. Peptide sequencing and phosphorylation site determina-
tion were achieved using a Finnigan ion trap mass spectrometer
operated with electrospray in the positive mode. Tandem MS (MS/
MS) was achieved through a data-dependent mode of operation,
i.e., a full scan MS was followed by MS/MS on the most intense
ion or on ions from a predeﬁned inclusion list. MS/MS data were
used to elucidate the sequence and phosphorylation site(s) of a pep-
tide. Quantitative information was derived from the MS signal inten-
sity and should be treated semi-quantitative.3. Results
To identify potential new Raf phosphorylation sites and
particularly to obtain quantitative data with respect to C-Raf phosphorylation, we analyzed active and non-activated
C-Raf kinases using a number of mass spectrometry (MS)
methods. For that purpose, GST-tagged C-Raf proteins were
expressed in Sf9 insect cells and puriﬁed by glutathione–
Sepharose aﬃnity chromatography. The purity of GST-
C-Raf preparations is documented in Fig. 2A. To reduce
the background signals in MS due to the addition of non-
ionic detergent Nonidet P-40, we puriﬁed C-Raf in the pres-
ence of octyl-glucoside, a non-ionic detergent that can easily
be removed. After concentration of Raf proteins, trypsin
digestion and liquid chromatography (LC) have been carried
out. The selective detection of the phosphopeptides has been
performed by Parent Ion Scanning using a triple quadruple
mass spectrometer. The molecular weights and sequence
informations have been obtained by Ion Trap LC/MS-MS/
MS. The results obtained for C-Raf phosphorylation are
listed in Table 1, and conﬁrm phosphorylations in the posi-
tions of serine 259 and 621, which represent previously char-
acterized 14-3-3 binding epitopes. The extend of these
phosphorylations amounted to 60% and 70% of the total
for pS259 and pS621, respectively. Whereas the phosphory-
lation in the position of serine 621 was unambiguously
determined, the MS data for peptides 257–275 did not oﬀer
the possibility to diﬀerentiate between the two sites of serine
257 and 259. However, based on our previous data (see Ref.
[4]) we propose that the phosphorylation monitored here
should be ascribed to that of serine 259. Active C-Raf-
Y340D/Y341D (C-Raf-DD) mutant and C-Raf wt revealed
practically the same degree of phosphorylation in positions
259 and 621, indicating that 14-3-3 protein binds to both
activated Raf and inactive Raf molecules. The phosphoryla-
tion of serine 43, which has been well documented [4], was
not detected (at least under the conditions of our analysis),
possibly due to the size of the tryptic fragment. We also did
not detect phosphorylation of serine 338, threonine 491, ser-
ine 494 and tyrosine 340/341 (in wild-type Raf, see Table 1).
These phosphorylations have been reported to be Ras-induc-
ible [5,12]. However, due to only marginal activation of
C-Raf by endogenous Ras in Sf9 insect cells, these phospho-
rylations were not detectable by the methods used. Similarly,
the phosphorylation of threonine 268/269 that has been as-
cribed to autophosphorylation [4] or KSR phosphorylation
[9] was not detected, indicating that phosphorylation in these
positions needs external stimulation or co-expression with
activated Ras. The PKC-dependent phosphorylation site ser-
ine 497 was phosphorylated to a low degree, however, only
in the active C-Raf mutant (Table 1). Moreover, we identi-
ﬁed two novel phosphorylation sites in C-Raf located in the
trypsin fragments 283–309. Importantly, the degree of phos-
phorylation in these positions varies depending on the activ-
ity status of C-Raf. As depicted in Table 1, wild-type C-Raf
exhibited 55 and 15% phosphorylation for serines 296 and
301, respectively. These values increased to 65% and 40%
in highly active C-Raf-DD mutant.
To provide more insight into the results obtained by MS
technology, particularly with respect to regulation of Raf
activation, we cloned C-Raf proteins containing mutations
(serine to alanine and serine to aspartic acid) in the posi-
tions of serine 296 and 301. Exchange of serine for aspartic
acid (D) was intended to mimick the phosphorylation state
of serine and has been used in similar studies [13]. As shown
in Fig. 2B, we were able to express and purify these mutated
Table 1
Peptides obtained by trypsin digestion of C-Raf wild-type and constitutively active C-Raf (C-Raf-Y340D/Y341D) are listed
Peptides (aa) Phosphorylation sites (%) Phosphorylation C-Raf
257–275 STSTPNVHMVSTTLPVDSR Ser 259 60 wt
60 DD
257–275 STSTPNVHMVSTTLPVDSR Thr 268/269 – wt
– DD
283–309 SHSESASPSALSSSPNNLSPTGWSQPK Ser 296/301 55/15 wt
65/40 DD
484–493 IGDFGLATVK Thr 491 – wt
– DD
494–518 SRWSGSQQVEQPTGSVLMAPEVIR Ser 497 – wt
10 DD
619–627 SASEPSLHR Ser 621 70 wt
70 DD
337–354 DSSYYWEIEASEVMLSTR DSSDDWEIEASEVMLSTR Ser 338/339 and Tyr 340/341 – wt
– DD
The degree of phosphorylation was analyzed using MS as described in Section 2.
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chromatography. The puriﬁed C-Raf wt and the mutated
proteins did not exhibit signiﬁcant diﬀerences with respect
to electrophoretic mobility and association properties with
HSP90 and 14-3-3 proteins (Fig. 2B). To study the possible
changes of C-Raf kinase activities as a function of phos-
phorylation in the positions of serine 296 and 301, C-Raf
wild-type and the mutated kinases were transfected into
COS-7 cells. Following EGF stimulation of the cells, kinase
activities of mutated C-Raf proteins were compared to that
of wild-type C-Raf. As demonstrated in Fig. 4, the exchange
of serine (S) by alanine (A) resulted in marked increase of
kinase activities. In contrast, in the case of the serine (S)
to aspartic acid (D) mutation we observed no signiﬁcant
change of kinase activities compared to wild-type C-Raf
(data not shown). Thus, the data presented in Fig. 4
strongly suggest that the phosphorylation of positions 296
and 301 plays a role in Raf activation cycle. C-Raf samples
co-expressed with Ras12V and Lck revealed very high levels
of kinase activity, thus, making it diﬃcult to distinguish be-
tween wt, S-A and S-D mutations with respect to kinase
activity (data not shown).Fig. 3. Sequence alignment of the tryptic fragment containing serine
296 and 301 for C-, A- and B-Raf.4. Discussion
Phosphorylation of Raf plays a crucial role in the Raf
activation process. Originally, Morrison et al. identiﬁed three
major phosphorylation sites in C-Raf isolated from PDGF-
activated NIH3T3 cells: serine residues at positions 43, 259
and 621 ([4], see also Fig. 1). Later, it was shown that phos-
phorylation of serine 338 accompanies Ras-dependent C-Raf
activation and may precede tyrosine phosphorylation at
positions 340 and 341 [6]. However, quantitative analysis
of C-Raf phosphorylation has not been performed so far.
Using MS we analyzed the phosphorylation status of C-
Raf wild-type and a constitutively active mutant of C-Raf(C-Raf-Y340D/Y341D). The degree of phosphorylation at
the 14-3-3 binding sites at serines 259 and 621 was similar
for both C-Raf samples analyzed, suggesting that 14-3-3
protein association does not discriminate between higher ac-
tive mutant and wild-type C-Raf kinases. We conﬁrmed
most of the previously described phosphorylation sites, with
the exception that we did not detect phosphorylation of
threonines 268/269, representing the in vitro auto-phosphor-
ylation sites. Similarly, we did not detect phosphorylation of
serine 338, threonine 491 and serine 494 (see Table 1, pep-
tides 484–493 and 494–518). We suggest that some of these
sites may be more important for subcellular localization of
C-Raf kinase rather than activation. Furthermore, we iden-
tiﬁed and described in this contribution two novel phosphor-
ylation sites in C-Raf kinase. The extent of phosphorylation
at these positions (serine 296 and 301) may represent a ﬁne
regulation in the course of Raf activation cycle. However,
regulation due to the phosphorylation in position 296 is pos-
sible only for C- and A-Raf, not for B-Raf, since only serine
301 is common to all Raf isoforms (see the sequence align-
ment of the tryptic fragment containing serines 296 and 301
for A-, B- and C-Raf, Fig. 3). Recently, Laird et al. [14] re-
ported about Raf phosphorylation with respect to mitotic
hyperphosphorylation. The authors investigated among
other sites the possible phosphorylations within C-Raf resi-


































Fig. 4. Kinase activity of C-Raf kinases. C-Raf wt and mutants (serine to alanine and serine to aspartic acid) were transfected into COS-7 cells using
Ca2+ phosphate precipitation method. Following EGF stimulation, C-Raf kinase activity was determined in the presence of puriﬁed MEK and ERK
proteins. After SDS–PAGE and Western blotting, ERK phosphorylation was detected by a phosphospeciﬁc ERK antibody. Western blot signals
were normalized for C-Raf content. C-Raf-BXB (catalytic domain of C-Raf) and C-Raf-K375W (kinase dead mutant of C-Raf) were used as positive
and negative controls, respectively. Similar results were obtained from three independent experiments.
468 M. Hekman et al. / FEBS Letters 579 (2005) 464–468as potential targets for phosphorylation (see also Fig. 1).
Interestingly, serine residues 287, 289 and 291 have been
found to represent mitosis-speciﬁc phosphorylation sites. In
contrast, serines 294, 295, 296 and 301 remained unchanged.
Taken together, the authors suggested that the mechanisms
responsible for C-Raf activation during mitosis are distinct
from those involved in Raf stimulation by growth factors
in G1 phase of the cell cycle [14]. These data are in agree-
ment with our present observations. We show in this contri-
bution that the active C-Raf-DD, corresponding to growth
factor activated Raf, contains increased phosphorylation at
residues serine 296 and 301, but not at residues serine 287,
289 and 291. Moreover, we demonstrated using mutated
C-Raf proteins that phosphorylation of serines 296 and
301 is important for C-Raf activation, since serine to alanine
mutagenesis resulted in elevation of kinase activity (Fig. 4).
Recently, ERK-mediated feedback phosphorylation sites at
the C-terminal part of B-Raf were identiﬁed [15]. As C-
and A-Raf do not possess such motifs at the C-termini, it
is tempting to speculate that serines 296 and 301 represent
the corresponding sites for feedback phosphorylation by
ERK or other MAP kinases in C-Raf. However, phosphor-
ylation in these positions may not only be important for the
activation cycle, but may also additionally specify C-Raf
subcellular location (e.g., facilitated release of C-Raf from
membranes). Preliminary results with respect to Raf localiza-
tion using GFP-labeled Raf kinases did not reveal signiﬁcant
diﬀerences between C-Raf and C-Raf 296 and 301 mutants
(data not shown). Finally, from a mechanistic point of view
we cannot exclude at the present time the possibility that
this epitope inﬂuences other important functions, such as
interactions of Raf with heat shock proteins [16], association
with14-3-3 proteins [17], Raf oligomerization [18] or complex
formation with KSR and other scaﬀold proteins. We are
currently investigating the putative functional role for the
phosphorylation of serines 296 and 301 with regard to the
Raf activation-deactivation process, using puriﬁed C-Raf
kinases and reconstitution techniques.Acknowledgments: We thank R. Metz and B. Bauer for excellent tech-
nical assistance and S. Albert for critical comments. This work was
supported by Deutsche Forschungsgemeinschaft Grant SFB 487, Pro-
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